Booster Therapeutics
Biotechnology company developing new drug modalities to eliminate toxic accumulations and reinstate cellular balance to address multiple degenerative diseases associated with aging.
Notes
Booster Therapeutics is a biotechnology company committed to developing innovative therapies that target the accumulation of toxic cellular materials associated with degenerative diseases and aging. The company's approach focuses on restoring cellular homeostasis by eliminating harmful accumulations that disrupt normal cell function.
Booster Therapeutics launched in October 2024 with $15 million in seed financing led by Apollo Health Ventures and Novo Holdings, two leading life sciences investors with strong track records in longevity and biotechnology investments.
Team
- Chief Executive Officer - To be announced
- Scientific leadership with expertise in cellular biology and drug discovery
Additional Research Findings
- Raised $15 million seed financing (October 2024)
- Lead investors: Apollo Health Ventures, Novo Holdings
- Focus on eliminating toxic cellular accumulations
- Targeting degenerative diseases
- Longevity research focus
- Novel drug modalities approach
- Copenhagen, Denmark headquarters
- Early-stage company building platform and pipeline
Sources
- Booster Therapeutics Official Website
- Apollo Health Ventures Portfolio
- Novo Holdings Portfolio
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apollo Health Ventures | Dusseldorf, Germany / Boston, USA | biotech-focused | seedseries-a+1 | 15 |
| Novo Holdings | Hellerup, Denmark | biotech-focused | seedseries-a+3 | 13 |